Examining outcomes in children with Down syndrome and acute lymphoblastic leukemia

Children with Down syndrome have an increased risk of developing acute lymphoblastic leukemia (ALL) and experience higher rates of relapse and treatment toxicity. In recent decades, new therapies have improved outcomes for the general population, but outcomes for children with Down syndrome have lagged and have not been reported for contemporary treatment regimens.

Read more: https://www.bcm.edu/news/examining-outcomes-in-children-with-down-syndrome-and-acute-lymphoblastic-leukemia